126 related articles for article (PubMed ID: 17888167)
21. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
Muris JJ; Ylstra B; Cillessen SA; Ossenkoppele GJ; Kluin-Nelemans JC; Eijk PP; Nota B; Tijssen M; de Boer WP; van de Wiel M; van den Ijssel PR; Jansen P; de Bruin PC; van Krieken JH; Meijer GA; Meijer CJ; Oudejans JJ
Br J Haematol; 2007 Jan; 136(1):38-47. PubMed ID: 17062006
[TBL] [Abstract][Full Text] [Related]
22. DNA microarrays in lymphoid malignancies.
Rosenwald A
Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
[TBL] [Abstract][Full Text] [Related]
23. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
Shipp MA; Ross KN; Tamayo P; Weng AP; Kutok JL; Aguiar RC; Gaasenbeek M; Angelo M; Reich M; Pinkus GS; Ray TS; Koval MA; Last KW; Norton A; Lister TA; Mesirov J; Neuberg DS; Lander ES; Aster JC; Golub TR
Nat Med; 2002 Jan; 8(1):68-74. PubMed ID: 11786909
[TBL] [Abstract][Full Text] [Related]
24. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
[TBL] [Abstract][Full Text] [Related]
25. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
26. A combinational feature selection and ensemble neural network method for classification of gene expression data.
Liu B; Cui Q; Jiang T; Ma S
BMC Bioinformatics; 2004 Sep; 5():136. PubMed ID: 15450124
[TBL] [Abstract][Full Text] [Related]
27. [Diffuse large B-cell lymphoma: therapeutic development based on clinical and biological heterogeneity].
Miyazaki K
Rinsho Ketsueki; 2015 Oct; 56(10):2047-55. PubMed ID: 26458444
[TBL] [Abstract][Full Text] [Related]
28. Cluster stability scores for microarray data in cancer studies.
Smolkin M; Ghosh D
BMC Bioinformatics; 2003 Sep; 4():36. PubMed ID: 12959646
[TBL] [Abstract][Full Text] [Related]
29. Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling.
Ando T; Suguro M; Kobayashi T; Seto M; Honda H
Cancer Sci; 2003 Oct; 94(10):906-13. PubMed ID: 14556665
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM
J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453
[TBL] [Abstract][Full Text] [Related]
31. Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP.
Wong KK; Ch'ng ES; Loo SK; Husin A; Muruzabal MA; Møller MB; Pedersen LM; Pomposo MP; Gaafar A; Banham AH; Green TM; Lawrie CH
Exp Mol Pathol; 2015 Dec; 99(3):537-45. PubMed ID: 26341140
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathogenesis of diffuse large B-cell lymphoma.
Lossos IS
J Clin Oncol; 2005 Sep; 23(26):6351-7. PubMed ID: 16155019
[TBL] [Abstract][Full Text] [Related]
33. Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?
Morin RD; Arthur SE; Hodson DJ
Br J Haematol; 2022 Feb; 196(4):814-829. PubMed ID: 34467527
[TBL] [Abstract][Full Text] [Related]
34. Diffuse large B cell lymphoma: from gene expression profiling to prediction of outcome.
Lossos IS
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):108-11. PubMed ID: 18162230
[TBL] [Abstract][Full Text] [Related]
35. Molecular heterogeneity of diffuse large B-cell lymphoma.
Gascoyne RD
Hematol J; 2004; 5 Suppl 3():S144-8. PubMed ID: 15190297
[No Abstract] [Full Text] [Related]
36. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
[TBL] [Abstract][Full Text] [Related]
37. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
38. Identification of disease-causing genes using microarray data mining and Gene Ontology.
Mohammadi A; Saraee MH; Salehi M
BMC Med Genomics; 2011 Jan; 4():12. PubMed ID: 21269461
[TBL] [Abstract][Full Text] [Related]
39. Pathway importance by graph convolutional network and Shapley additive explanations in gene expression phenotype of diffuse large B-cell lymphoma.
Hayakawa J; Seki T; Kawazoe Y; Ohe K
PLoS One; 2022; 17(6):e0269570. PubMed ID: 35749395
[TBL] [Abstract][Full Text] [Related]
40. Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral Heterogeneity.
Nissen MD; Kusakabe M; Wang X; Simkin G; Gracias D; Tyshchenko K; Hill A; Meskas J; Hung S; Chavez EA; Ennishi D; Aoki T; Sarkozy C; Connors JM; Farinha P; Slack GW; Gascoyne RD; Brinkman RR; Scott DW; Steidl C; Weng AP
Cytometry A; 2020 Jun; 97(6):620-629. PubMed ID: 31637838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
